Yazar "Wiendl, H." için listeleme

Toplam kayıt 2, listelenen: 1-2

Comparative analysis of MS outcomes in natalizumab-treated patients using a novel three-way multinomial propensity score match

Spelman, T.; Pellegrini, F.; Zhang, A.; Trojano, M.; Wiendl, H.; Kappos, L.; Butzkueven, H. (Sage Publications Ltd, 2016)

…
Comparative efficacy of first-line natalizumab versus IFNb or glatiramer acetate in relapsing MS

Spelman, T.; Kalincik, T.; Jokubaitis, V.; Zhang, A.; Pellegrini, F.; Wiendl, H.; Lechner-Scott, J. (Sage Publications Ltd, 2015)

…